Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors
about
Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreasNeurofunctional imaging of β-cell dynamicsImaging pancreatic islet cells by positron emission tomographyVMAT2 gene expression and function as it applies to imaging beta-cell massRole of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazineImaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligandsDecreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PETObstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis.A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitroPancreatic innervation in mouse development and beta-cell regeneration.Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.Imaging of beta-cell mass and functionIn vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective.11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system.Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes.In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.Visualizing pancreatic beta-cell mass with [11C]DTBZ.Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.Advances in molecular imaging of pancreatic beta cellsLocalization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of 18F-FP-DTBZ in baboonsSpecies-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.Targets and probes for non-invasive imaging of β-cells.Imaging the islet graft by positron emission tomography.Molecular imaging: a promising tool to monitor islet transplantation.Beta-cell imaging: call for evidence-based and scientific approach.Imaging beta-cell mass and function in situ and in vivo.Pancreatic β-cell imaging in humans: fiction or option?Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.Novel hypoglycemic dihydropyridones serendipitously discovered from O- versus C-alkylation in the synthesis of VMAT2 antagonists.PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
P2860
Q24653211-D90C0FF8-4987-4C8B-84E0-4F8DE3EEB709Q26829645-3505B199-E321-4EC5-8F2C-47E19A12846BQ28075496-CA0D8A31-7AE6-45C9-9BA4-B036B4317E7AQ28238649-7456C27C-70CE-48A0-96DD-AA1D277BDF0FQ28565154-CE85EC7C-F51E-4492-8304-2367E9B74FF4Q33812606-54AA68F0-ADF3-45D6-91B7-472E614149E9Q34619649-F729932C-C2A8-4721-A52C-CB71C961FCE5Q34657303-F0E6673F-57EF-4C58-9322-E88960804C01Q35651214-D924F158-B373-4C0F-B0BD-9C9944C5A992Q35772055-EF34BC1C-3C71-4FEC-990B-ABDF42337030Q35895009-D1EA231B-71A9-4C50-B8A2-F40B511566B1Q36128614-E6C271C8-A0BA-459F-AF13-93CA0F05AD3EQ36279518-871195B7-585F-4242-9626-D86F4ACED725Q36464477-ECC5D65A-3043-40F0-A847-BB4FB1D18A59Q36521985-C6A4F9C1-C782-4FCC-91B0-3FD8A27F6FADQ36665699-B33A3DC2-A1B5-4D42-A2BD-7BE5101A603DQ36707357-1643C045-5994-4FE5-AD8A-B6DDD7175D80Q36749622-362DFB91-DFDE-4A66-856F-DB16D864C58DQ36773604-62FBC99A-1C49-491F-9217-F5507557B286Q36774879-0A60DED9-5E7A-463E-81F5-34D3947EC328Q36996150-7E373242-FDFF-4713-953A-75C29C6A5C8CQ37013071-1A6B4922-C488-41F3-8DED-5FB4BF1BBBCFQ37080859-10C6D809-DC56-4349-BB4A-05BC4D44A576Q37094838-1A3E5B9F-DF53-48E7-9AF7-754E0A222487Q37406074-10860CF6-F162-47DD-8E65-C3EBE34CC4B6Q37466693-73BC14A5-3B62-4EFB-A7AF-14A8EA099DAAQ37591449-65ACF023-C35E-4EC2-ADC3-154EA39269DCQ37596164-A9A438EE-28FC-43D7-8B17-7276347D5028Q37640085-8C172AA9-720C-4AA7-AC38-530904E07FBAQ37662672-4B4AD41C-F039-48A7-B83C-CE3A84B7A4FDQ37935646-F494549E-155D-442C-B900-B5CC69303FE9Q37947597-6AD78A95-8529-4093-8472-A6D87F61CD39Q38081852-D98F1A72-2C54-4DAA-816B-CC20C6A0ABECQ38108757-643D76A5-AF7E-44A2-9620-5C4B645EAED8Q38558006-65CF5907-986C-4BDC-8283-91CC41ADE381Q38626655-0A1BDA71-8DF1-4818-9672-5DD1107045F5Q38800009-1667D993-5AF5-4C32-B3FE-1ED0534CC1B8Q38876299-1C0FA50C-ABAC-40EB-BDC1-1BE4EF0B2E44Q39992795-5F2D71DE-B50A-4C11-981D-1E1D3AC02943Q42149421-FA63A35F-D3A6-4C9B-B3CD-507AE829947A
P2860
Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors
description
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im August 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: August 2003)
@en
vedecký článok (publikovaný 2003-08)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd in 2003-08)
@nl
наукова стаття, опублікована в серпні 2003
@uk
مقالة علمية (نشرت في أغسطس 2003)
@ar
name
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@ast
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@en
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@nl
type
label
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@ast
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@en
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@nl
prefLabel
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@ast
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@en
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@nl
P2093
P2860
P3181
P1476
Expression of the two isoforms ...... nd pancreatic endocrine tumors
@en
P2093
Eberhard Weihe
Lee E Eiden
Martin Anlauf
Martin K-H Schäfer
Rolf Eissele
Rudolf Arnold
Ursula Pauser
P2860
P304
P3181
P356
10.1177/002215540305100806
P407
P577
2003-08-01T00:00:00Z